Skip to content

Research of Laser Ablation for the Treatment of Lower Anogenital Tracts' Precancerous Lesions

Research of Multiple Targeting CO2 Laser Ablation for the Treatment of Lower Anogenital Tracts' Precancerous Lesions

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05170620
Enrollment
200
Registered
2021-12-28
Start date
2019-11-08
Completion date
2024-12-31
Last updated
2021-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous Intraepithelial Lesions, Laser Burn

Keywords

laser, Cervical intraepithelial neoplasia, Vaginal intraepithelial neoplasia, Vulvar intraepithelial neoplasia, Anal intraepithelial neoplasia, Perianal intraepithelial neoplasia

Brief summary

Using multiple targeting CO2 laser ablation to treat the precancerous lesion of the female lower anogenital tracts and analyzing the data collected in the study, we aim to form the standard strategy of laser ablation method to increase the effective rate and lower the rate of relapse and progression.

Detailed description

Patients diagnosed with CIN, VaIN, VIN, AIN or PAIN are recruited with exclusion of suspicion of malignant tumors. We use multiple targeting CO2 laser ablation to treat the precancerous lesion of the female lower anogenital tracts and then follow up the patients for at least two years. By analyzing the data collected in the study, we aim to form the standard strategy of laser ablation method to increase the effective rate and lower the rate of relapse and progression.

Interventions

Laser ablation will be done for the squamous intraepithelial lesions of the lower anogenital tracts.

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Had the history of sexual life. 2. Transferred to colposcopy examination and biopsy for abnormal screening of cervical cancer, contact bleeding of cervix, recurrent discomfort of vulva or abnormal signs of lower genital and anal tract. The pathology of biopsy indicate CIN, VaIN, VIN, AIN, or PaIN. 3. If CIN, the colposcopy manifests transformation zone-1 which means the lesion can totally be seen. However the consideration of fertility damage of resection overweighs the chance of suffering cancer. 4. The patients can accept multiple laser ablations and colposcopy examinations and follow-up at least 2 years.

Exclusion criteria

1. Patients who are suffering cancers of other systems and in treatment. 2. Patients suffering acute inflammation of lower genital and anal tracts. 3. The colposcopy and pathology examination suspect of cancer of lower genital and anal tract. 4. Patients suffering severe diseases such as insufficiency of liver and kidney function, diseases of blood system and other acute infections who will get heath harm from colposcopy and laser vaporization.

Design outcomes

Primary

MeasureTime frameDescription
Pathological cureup to at least two yearsNo squamous intraepithelial lesions found by pathological examinations.

Secondary

MeasureTime frameDescription
HPV clearanceEvery six months after initial treatment for at least two yearsThe results of HPV tests are negative.

Countries

China

Contacts

Primary ContactShuang Li, Doctor
lee5190008@126.com+86 18971625668
Backup ContactDongli Kong, Doctor
kongdongli1988@163.com+86 15107173860

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026